Cetylpyridinium chloride monohydrate

Suppliers

Names

[ Name ]:
Cetylpyridinium chloride monohydrate

[Synonym ]:
Cetylpyridinum chloride
Cetylpyridinium chloride monohydrate
CETYLPYRIDINII CHLORIDUM
MFCD00149977
CPC MONOHYDRATE
EINECS 204-593-9
Pyridinium, 1-hexadecyl-, chloride, hydrate (1:1:1)
cetylpyridinium chloride
Chlorohexadecyl pyridine
Ceetylpyridiniumchloride
1-Hexadecylpyridin-1-ium chloride hydrate
Cetylpyridinium chloride hydrate
hexadecylpyridium chloride
cetyl pyridium chloride
1-Hexadecylpyridinium chloride hydrate (1:1:1)
Halset
N-CETYLPYRIDINIUM CHLORIDE MONOHYDRATE
Hexadecylpyridinium Chloride Monohydrate
Dobendan
Sprol
1-cetylpyridin-1-ium chloride hydrate
CPC
1-hexadecylpyridinium chloride monohydrate
N-hexadecylpyridinium chloride monohydrate
CPC hydrate
CETYL PYRIDIMUM CHLORIDE

Chemical & Physical Properties

[ Melting Point ]:
81-84 °C

[ Molecular Formula ]:
C₂₁H₄₀ClNO

[ Molecular Weight ]:
358.001

[ Exact Mass ]:
357.279846

[ PSA ]:
13.11000

[ LogP ]:
3.39510

[ Stability ]:
Stable. Combustible. Incompatible with strong oxidizing agents, acids, acid anhydrides, acid chlorides.

MSDS

Click to get detail MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :: UU5075000

CHEMICAL NAME :: Pyridinium, 1-hexadecyl-, chloride, monohydrate

CAS REGISTRY NUMBER :: 6004-24-6

LAST UPDATED :: 199603

DATA ITEMS CITED :: 8

MOLECULAR FORMULA :: C21-H38-N.Cl.H2-O

MOLECULAR WEIGHT :: 358.07

WISWESSER LINE NOTATION :: T6KJ A16 &G &QH

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 15 mg/kg

TOXIC EFFECTS :: Behavioral - somnolence (general depressed activity)

REFERENCE :: JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 74,401,1942

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 3 mg/kg

TOXIC EFFECTS :: Behavioral - somnolence (general depressed activity)

REFERENCE :: JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 74,401,1942

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Mammal - dog

DOSE/DURATION :: 100 mg/kg

TOXIC EFFECTS :: Peripheral Nerve and Sensation - flaccid paralysis without anesthesia (usually neuromuscular blockage)

REFERENCE :: JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 74,401,1942

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rabbit

DOSE/DURATION :: 400 mg/kg

TOXIC EFFECTS :: Gastrointestinal - hypermotility, diarrhea

REFERENCE :: JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 74,401,1942

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - rabbit

DOSE/DURATION :: 5 mg/kg

TOXIC EFFECTS :: Behavioral - somnolence (general depressed activity)

REFERENCE :: JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 74,401,1942

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - rabbit

DOSE/DURATION :: 200 mg/kg

TOXIC EFFECTS :: Behavioral - somnolence (general depressed activity)

REFERENCE :: JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 74,401,1942

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - rabbit

DOSE/DURATION :: 20 mg/kg

TOXIC EFFECTS :: Behavioral - somnolence (general depressed activity) Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - other changes

REFERENCE :: JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 74,401,1942

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - guinea pig

DOSE/DURATION :: 5 mg/kg

TOXIC EFFECTS :: Behavioral - somnolence (general depressed activity)

REFERENCE :: JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 74,401,1942

Safety Information

[ Symbol ]:

GHS06, GHS09

[ Signal Word ]:
Danger

[ Hazard Statements ]:
H301-H315-H319-H330-H335-H410

[ Precautionary Statements ]:
P260-P304 + P340 + P310-P305 + P351 + P338-P403 + P233

[ Personal Protective Equipment ]:
Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges

[ Hazard Codes ]:
T+:Verytoxic;

[ Risk Phrases ]:
R25;R26;R38

[ Safety Phrases ]:
S28-S36/37-S45-S7/9-S61-S26

[ RIDADR ]:
UN 2811 6.1/PG 1

[ WGK Germany ]:
3

[ RTECS ]:
UU5075000

[ Packaging Group ]:
I

[ Hazard Class ]:
6.1

[ HS Code ]:
2933399090

Customs

[ HS Code ]: 2933399090

[ Summary ]:
2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Articles

Exosomes: novel effectors of human platelet lysate activity.

Eur. Cell. Mater. 28 , 137-51; discussion 151, (2014)

Despite the popularity of platelet-rich plasma (PRP) and platelet lysate (PL) in orthopaedic practice, the mechanism of action and the effectiveness of these therapeutic tools are still controversial....

Impact of lipid dynamic behavior on physical stability, in vitro release and skin permeation of genistein-loaded lipid nanoparticles.

Eur. J. Pharm. Biopharm. 88(1) , 40-7, (2014)

The aim of this study was to develop lipid nanoparticles to deliver genistein (GEN) to deeper skin layers. To do so, the impact of lipid dynamic behavior (nanoparticle flexibility) on stability, relea...

Effect of silver nanoparticles on human mesenchymal stem cell differentiation.

Beilstein J. Nanotechnol. 5 , 2058-69, (2014)

Silver nanoparticles (Ag-NP) are one of the fastest growing products in nano-medicine due to their enhanced antibacterial activity at the nanoscale level. In biomedicine, hundreds of products have bee...

cetylpyridinium chloride
TETRAPHENYLARSONIUM CHLORIDE MONOHYDRATE
Guaninium chloride monohydrate
cerium chloride monohydrate
Barium chloride monohydrate
cerium chloride monohydrate
4'-Hydroxy-N-acetyl-4-aminobibenzyl
4,5-Dibromothiophene-2-carbothioic O-acid
1-Cyclobutyl-3-(prop-2-enoyl)urea
4-chloro-N-(3-oxo-1,2,4-thiadiazol-5-yl)benzamide
3-(1-butyrylpiperidin-3-yl)-4-cyclopropyl-1-(2-methoxyethyl)-1H-1,2,4-triazol-5(4H)-one
1-[2-(4-Ethoxyphenyl)-2-methylpropyl]-3-phenoxybenzene
Glycine, N-carboxy-, N-o-chlorobenzyl ethyl ester
4-(((4,7-Dichlorobenzo[d]oxazol-2-yl)methyl)amino)-1-methyl-5,6,7,8-tetrahydroisoquinolin-3(2h)-one
Carbamic acid, N-(4-ethylphenyl)-, (2-bromophenyl)methyl ester
Ethyl-2-oxo-2-(2-benzothienyl)acetate

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.